4//SEC Filing
Besch Doug 4
Accession 0001628280-25-041108
CIK 0001448431other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 3:16 PM ET
Size
7.5 KB
Accession
0001628280-25-041108
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Besch Doug
Chief Product Officer
Transactions
- Award
Stock Option
2025-08-21+35,156→ 35,156 totalExercise: $16.14From: 2026-08-21Exp: 2030-08-21→ Common Stock (35,156 underlying) - Award
Common Stock
2025-08-21+15,625→ 67,230 total
Footnotes (2)
- [F1]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.
- [F2]The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001947731
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 3:16 PM ET
- Size
- 7.5 KB